Abstract Although protein–protein interactions (PPIs) have emerged as the basis of potential new therapeutic approaches, targeting intracellular PPIs with small molecule inhibitors is conventionally considered highly challenging. Driven by increasing research efforts, success rates have increased significantly in recent years. In this study, we analyze the physicochemical properties of 9351 non-redundant inhibitors present in the iPPI-DB and TIMBAL databases to define a computational model for active compounds acting against PPI targets. Principle component analysis (PCA) and k-means clustering were used to identify plausible PPI targets in regions of interest in the active group in the chemical space between active and inactive iPPI compou...
The specific properties of protein–protein interactions (PPI) (flat, large and hydrophobic) make the...
Protein-protein interactions (PPI) were once considered 'undruggable', but clinical successes, drive...
Protein-protein interactions (PPIs) represent an enormous source of opportunity for therapeutic inte...
Although protein-protein interactions (PPIs) have emerged as the basis of potential new therapeutic ...
International audienceProtein-protein interactions (PPIs) may represent one of the next major classe...
Molecular descriptors have been used to characterize and predict the functions of small molecules, i...
International audienceProtein-protein interactions (PPIs) mediate nearly every cellular process and ...
International audienceProtein-protein interactions (PPI) are involved in vital cellular processes an...
Given the difficulties to identify chemical probes that can modulate protein–protein interactions (P...
BackgroundProtein-protein interactions (PPIs) are intriguing targets for designing novel small-molec...
Protein–protein interaction (PPI) inhibitors have an increasing role in drug discovery. It is hypoth...
Protein–protein interactions (PPIs) are recognized as important targets in drug discovery. The chara...
The large size and variety of the human protein interactome and the obvious relevance of the protein...
Background: In the last decade, the inhibition of protein-protein interactions (PPIs) has emerged fr...
Protein-protein interactions (PPIs) control the assembly of multi-protein complexes and, thus, these...
The specific properties of protein–protein interactions (PPI) (flat, large and hydrophobic) make the...
Protein-protein interactions (PPI) were once considered 'undruggable', but clinical successes, drive...
Protein-protein interactions (PPIs) represent an enormous source of opportunity for therapeutic inte...
Although protein-protein interactions (PPIs) have emerged as the basis of potential new therapeutic ...
International audienceProtein-protein interactions (PPIs) may represent one of the next major classe...
Molecular descriptors have been used to characterize and predict the functions of small molecules, i...
International audienceProtein-protein interactions (PPIs) mediate nearly every cellular process and ...
International audienceProtein-protein interactions (PPI) are involved in vital cellular processes an...
Given the difficulties to identify chemical probes that can modulate protein–protein interactions (P...
BackgroundProtein-protein interactions (PPIs) are intriguing targets for designing novel small-molec...
Protein–protein interaction (PPI) inhibitors have an increasing role in drug discovery. It is hypoth...
Protein–protein interactions (PPIs) are recognized as important targets in drug discovery. The chara...
The large size and variety of the human protein interactome and the obvious relevance of the protein...
Background: In the last decade, the inhibition of protein-protein interactions (PPIs) has emerged fr...
Protein-protein interactions (PPIs) control the assembly of multi-protein complexes and, thus, these...
The specific properties of protein–protein interactions (PPI) (flat, large and hydrophobic) make the...
Protein-protein interactions (PPI) were once considered 'undruggable', but clinical successes, drive...
Protein-protein interactions (PPIs) represent an enormous source of opportunity for therapeutic inte...